Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine O'Doherty

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cytokine & Growth Factor Reviews|June 2, 2007
Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genesCatherine O'Doherty, Pablo Villoslada, Koen Vandenbroeck
Autoimmunity Reviews|November 6, 2013
Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literatureSunil Mahurkar, Vijayaprakash Suppiah, Catherine O'Doherty
The New England Journal of Medicine|February 15, 2008
IL7RA polymorphisms and susceptibility to multiple sclerosisCatherine O'Doherty, Orhun Kantarci, Koen Vandenbroeck
Expert Opinion on Drug Metabolism & Toxicology|June 10, 2014
Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicineMichael D Wiese, Vijayaprakash Suppiah, Catherine O'Doherty
Plos One|March 8, 2013
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatmentSunil Mahurkar, Max Moldovan, Vijayaprakash Suppiah, et al.
Journal of Substance Use|October 2, 2015
Beverage- and Brand-Specific Binge Alcohol Consumption among Underage Youth in the U.STimothy S Naimi, Michael Siegel, William DeJong, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2013
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosisMichael D Wiese, Andrew Rowland, Thomas M Polasek, et al.
Journal of Neuroimmunology|August 11, 2007
ITGA4 polymorphisms and susceptibility to multiple sclerosisCatherine O'Doherty, Izaura M Roos, Alfredo Antiguedad, et al.
Journal of Neuroimmunology|December 19, 2006
The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosisStephen Cunningham, Catherine O'Doherty, Chris Patterson, et al.
Pharmacogenomics|September 13, 2012
Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritisCatherine O'Doherty, Matthew Schnabl, Llewellyn Spargo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cytokine & Growth Factor Reviews|June 2, 2007
Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genesCatherine O'Doherty, Pablo Villoslada, Koen Vandenbroeck
Autoimmunity Reviews|November 6, 2013
Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literatureSunil Mahurkar, Vijayaprakash Suppiah, Catherine O'Doherty
The New England Journal of Medicine|February 15, 2008
IL7RA polymorphisms and susceptibility to multiple sclerosisCatherine O'Doherty, Orhun Kantarci, Koen Vandenbroeck
Expert Opinion on Drug Metabolism & Toxicology|June 10, 2014
Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicineMichael D Wiese, Vijayaprakash Suppiah, Catherine O'Doherty
Plos One|March 8, 2013
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatmentSunil Mahurkar, Max Moldovan, Vijayaprakash Suppiah, et al.
Journal of Substance Use|October 2, 2015
Beverage- and Brand-Specific Binge Alcohol Consumption among Underage Youth in the U.STimothy S Naimi, Michael Siegel, William DeJong, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2013
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosisMichael D Wiese, Andrew Rowland, Thomas M Polasek, et al.
Journal of Neuroimmunology|August 11, 2007
ITGA4 polymorphisms and susceptibility to multiple sclerosisCatherine O'Doherty, Izaura M Roos, Alfredo Antiguedad, et al.
Journal of Neuroimmunology|December 19, 2006
The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosisStephen Cunningham, Catherine O'Doherty, Chris Patterson, et al.
Pharmacogenomics|September 13, 2012
Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritisCatherine O'Doherty, Matthew Schnabl, Llewellyn Spargo, et al.
Pageof 2